No Data
CR Sanjiu Logs 18% Boost in 2024 Profit
China Resources 39:2024 Annual Report Summary
China Resources 39:2024 Annual Report
Gelonghui Announcement Highlights | China Resources Sanjiu Medical & Pharmaceutical: Net income is expected to increase by 18.05% year-on-year in 2024, proposed a 10-for-3 stock split with a distribution of 3.2 yuan; Weichai Heavy Machinery: The company's
【Hot Topic】 Henggong Precision (301261.SZ): The revenue from the related business in the fields of robot reducers and humanoid robots is relatively low. Guangxi Radio and Television Information Network Corporation (600936.SH): The Technology subsidiary "Guangdian Cloud" has integrated multiple large models including DeepSeek and QWen (Qianwen), currently this deployment is mainly applied in intelligent customer service scenarios. Garden Share Co., Ltd. (605303.SH): Cloud Needle Technology is currently in the early stage of technology achievement transformation, with a small business scale and still in a loss state. Weichai Heavy Machinery (000880.SZ): The company's Generator product can be used in Datacenters.
China Resources Sanjiu Medical & Pharmaceutical (000999.SZ): In 2024, the Net income increased by 18.05% year-on-year, proposing a distribution of 3.2 yuan for every 10 shares through a stock split.
On March 12, Gronghui reported that China Resources Sanjiu Medical & Pharmaceutical (000999.SZ) released its annual report for 2024. In 2024, the company achieved revenue of 27.617 billion yuan, an increase of 11.63% compared to the same period last year; the company achieved a net cash flow from operating activities (CFO) of 4.402 billion yuan, an increase of 5.02% year-on-year; it realized a net income attributed to shareholders of the listed company of 3.368 billion yuan, a growth of 18.05% compared to the same period last year; the net income attributed to shareholders of the listed company, excluding non-recurring gains and losses, was 3.118 billion yuan, an increase of 15.01% year-on-year. A dividend will be distributed to all shareholders for every 1...
Express News | China Resources Sanjiu Medical & Pharmaceutical Says 2024 Net Profit up 18.1% Y/Y
China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Investors Will Be Pleased With Their Strong 123% Return Over the Last Three Years
